1. Complement C3 inhibitor pegcetacoplan for geographic atrophy secondary to age-related macular degeneration: a randomized phase 2 trial;Liao;Ophthalmology,2020
2. Apellis. Apellis announces detailed results from phase 3 DERBY and OAKS studies presented at Retina Society Annual Meeting. Accessed November 9, 2021. https://investors.apellis.com/news-releases/news-release-details/apellis-announces-detailed-results-phase-3-derby-and-oaks
3. Clinical classification of age-related macular degeneration;Ferris;Ophthalmology,2013
4. Advances in age-related macular degeneration understanding and therapy;Miller;US Ophthalmic Rev,2017
5. Prevalence of age-related macular degeneration in the United States;Friedman;Arch Ophthalmol,2004